DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Unipolar Depression | Access and Reimbursement | Major Depressive Disorder | US | 2019
Numerous drugs from multiple drug classes are used as monotherapies and/or adjunctive therapies for the treatment of major depressive disorder (MDD). The MDD treatment armamentarium is becoming…
Major Depressive Disorder | Treatment Algorithms | Claims Data Analysis | US | 2019
In the United States a plethora of pharmacological treatments from an array of drug classes are available to patients with major depressive disorder (MDD), a highly drug-treated condition. Though…
Suicidal Ideation in Major Depressive Disorder | Treatment Algorithms | Claims Data Analysis | US | 2018
A subset of major depressive disorder (MDD) patients experience suicidal ideation (SID). Because of the potential lethality of SID, SID in MDD is a highly drug-treated condition that uses an array…
Unipolar Depression | Treatment Algorithms: Claims Data Analysis | Major Depressive Disorder | US | 2017
MARKET OUTLOOK MDD is a highly drug-treated condition that utilizes an array of drug classes, including, but not limited to, SSRI , SNRI s, and—as adjunctive therapies—atypical…
